Repurposing FDA approved drugs as possible anti-SARS-CoV-2 medications using ligand-based computational approaches: sum of ranking difference-based model selection | Zendy

AI Assistant Blog Pricing

Repurposing FDA approved drugs as possible anti-SARS-CoV-2 medications using ligand-based computational approaches: sum of ranking difference-based model selection

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.